-
Diabetes, inhaled corticosteroids may be linked, study finds
NEW YORK — A link may exist between diabetes and the use of inhaled corticosteroids to treat asthma and chronic obstructive pulmonary disease, according to published reports.
HealthDay News reported that researchers analyzed data on 380,000 patients in Quebec, finding a 34% increase in the rate of new diagnoses of diabetes and progression of the disease among those who used inhalers, with greater risk among those using higher doses.
-
Eulactol USA rebrands company as Laderma Health USA
BOCA RATON, Fla. — Eulactol USA, the maker of Flexitol and Natralia brand products, on Friday announced its official corporate name change to Laderma Health USA, effective Jan. 1.
“This new name is better aligned with our long-term strategy, products and categories encompassing skin care and health and well-being products,” stated John Swigert, VP of Laderma Health USA. “We feel this is a very positive step for our company and portrays us more accurately in the marketplace.”